282 related articles for article (PubMed ID: 22823000)
21. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease.
Makris M; Federici AB; Mannucci PM; Bolton-Maggs PHB; Yee TT; Abshire T; Berntorp E
Haemophilia; 2015 May; 21(3):338-342. PubMed ID: 25381842
[TBL] [Abstract][Full Text] [Related]
22. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL Study.
Federici AB
Haemophilia; 2007 Dec; 13 Suppl 5():15-24. PubMed ID: 18078393
[TBL] [Abstract][Full Text] [Related]
23. Clinical diagnosis of von Willebrand disease.
Federici AB
Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
[TBL] [Abstract][Full Text] [Related]
24. von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease.
Sidonio RF; Boban A; Dubey L; Inati A; Kiss C; Boda Z; Lissitchkov T; Nemes L; Novik D; Peteva E; Taher AT; Timofeeva MA; Vilchevska KV; Vdovin V; Werner S; Knaub S; Djambas Khayat C
Blood Adv; 2024 Mar; 8(6):1405-1414. PubMed ID: 38237075
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study.
Federici AB; Baudo F; Caracciolo C; Mancuso G; Mazzucconi MG; Musso R; Schinco PC; Targhetta R; Mannuccio Mannucci P
Haemophilia; 2002 Nov; 8(6):761-7. PubMed ID: 12410644
[TBL] [Abstract][Full Text] [Related]
26. Von Willebrand's disease: clinical management.
Federici AB; Castaman G; Thompson A; Berntorp E
Haemophilia; 2006 Jul; 12 Suppl 3():152-8. PubMed ID: 16684011
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
Berntorp E
Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
[TBL] [Abstract][Full Text] [Related]
28. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
29. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
Berntorp E; Windyga J;
Haemophilia; 2009 Jan; 15(1):122-30. PubMed ID: 19149848
[TBL] [Abstract][Full Text] [Related]
30. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.
Tosetto A; Badiee Z; Baghaipour MR; Baronciani L; Battle J; Berntorp E; Bodó I; Budde U; Castaman G; Eikenboom JCJ; Eshghi P; Ettorre C; Goodeve A; Goudemand J; Hay CRM; Hoorfar H; Karimi M; Keikhaei B; Lassila R; Leebeek FWG; Lopez Fernandez MF; Mannucci PM; Mazzucconi MG; Morfini M; Oldenburg J; Peake I; Parra Lòpez R; Peyvandi F; Schneppenheim R; Tiede A; Toogeh G; Trossaert M; Zekavat O; Zetterberg EMK; Federici AB
J Thromb Haemost; 2020 Sep; 18(9):2145-2154. PubMed ID: 32379400
[TBL] [Abstract][Full Text] [Related]
31. Fanhdi, efficacy and safety in von Willebrand's disease: prospective international study results.
Bello IF; Yuste VJ; Molina MQ; Navarro FH
Haemophilia; 2007 Dec; 13 Suppl 5():25-32. PubMed ID: 18078394
[TBL] [Abstract][Full Text] [Related]
32. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study.
Mannucci PM; Chediak J; Hanna W; Byrnes J; Ledford M; Ewenstein BM; Retzios AD; Kapelan BA; Schwartz RS; Kessler C;
Blood; 2002 Jan; 99(2):450-6. PubMed ID: 11781224
[TBL] [Abstract][Full Text] [Related]
33. Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.
van Galen KPM; Sanders YV; Vojinovic U; Eikenboom J; Cnossen MH; Schutgens REG; van der Bom JG; Fijnvandraat K; Laros-Van Gorkom BAP; Meijer K; Leebeek FWG; Mauser-Bunschoten EP;
Haemophilia; 2015 May; 21(3):e185-e192. PubMed ID: 25854528
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
36. Translating the success of prophylaxis in haemophilia to von Willebrand disease.
Miesbach W; Berntorp E
Thromb Res; 2021 Mar; 199():67-74. PubMed ID: 33445035
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review.
El Alayli A; Brignardello Petersen R; Husainat NM; Kalot MA; Aljabiri Y; Turkmani H; Britt A; El-Khechen H; Shahid S; Roller J; Motaghi S; Mansour R; Tosetto A; Abdul-Kadir R; Laffan M; Weyand A; Leebeek FWG; Arapshian A; Kouides P; James P; Connell NT; Flood VH; Mustafa RA
Haemophilia; 2022 May; 28(3):373-387. PubMed ID: 35339117
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease.
Rugeri L; Harroche A; Repessé Y; Desprez D; Petesch BP; Chamouni P; Biron C; Frotscher B; Catovic H; Bracquart D; Martin C; Trossaërt M; Meunier S; d'Oiron R
Eur J Haematol; 2022 Jul; 109(1):109-117. PubMed ID: 35438801
[TBL] [Abstract][Full Text] [Related]
39. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrate.
Hernandez-Navarro F; Quintana M; Jimenez-Yuste V; Alvarez MT; Fernandez-Morata R
Haemophilia; 2008 Sep; 14(5):963-7. PubMed ID: 18624696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
